Angiogenesis in cancer, vascular, rheumatoid and other disease.
Journal: 1995/December - Nature Medicine
ISSN: 1078-8956
PUBMED: 7584949
Abstract:
Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Relations:
Citations
(1K+)
Clinical trials
(1)
Diseases
(3)
Conditions
(2)
Chemicals
(7)
Organisms
(3)
Processes
(1)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.